The two molecules sit in the same melanocortin neighbourhood, but their receptor profiles, evidence bases, regulatory histories, and sourcing cautions are materially different
Complementary strategies that support peptide protocols Peptides do not work in isolation
Our team of experts along with our broad portfolio makes it easy to: Screen for inhibitors/targets using our GIP and cell-based assays Obtain IC 50 or EC 50 determination or single point concentrations of compound series Perform follow-up studies Get questions answered or project guidance in a time-efficient manner Save time and resources by skipping assay or cell line development
One is a selective MC1R agonist that has passed phase III human trials, with its safety backed by years of clinical data and full regulatory approval in the EU and USA
It involves more pressure and manipulation, hence it is not comfortable when carried out by local anesthesia
By purchasing, you confirm you are a qualified researcher or institution acquiring this material for lawful research purposes
